ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,749.00
0.00%
S&P ASX All Technology
3,067.50
0.00%
Brent Oil
82.585
0.00%
US Dollar vs AUD
1.51461
0.46%
Bitcoin
61,225.24
0.70%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Vor Biopharma Inc (VOR)

  7. Vor Biopharma Inc (VOR) News

VOR

Vor Biopharma (VOR)

Vor Biopharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:VOR
DateTimeSourceHeadlineSymbolCompany
10/05/202406:05GlobeNewswire Inc.Vor Bio Reports First Quarter 2024 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
10/05/202406:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
08/05/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
08/05/202406:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
06/05/202422:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
04/05/202406:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
03/05/202406:01GlobeNewswire Inc.Vor Bio Appoints Accomplished Oncology and Cancer Immunotherapy R&D Executive, Fouad Namouni, M.D., to its Board of DirectorsNASDAQ:VORVor Biopharma Inc
01/04/202423:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
21/03/202407:05GlobeNewswire Inc.Vor Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
06/03/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
06/03/202408:15Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
06/03/202408:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
05/03/202400:00GlobeNewswire Inc.Vor Bio to Participate in Upcoming Investor ConferencesNASDAQ:VORVor Biopharma Inc
15/02/202408:08Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:VORVor Biopharma Inc
09/02/202409:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
09/02/202409:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
08/02/202400:00GlobeNewswire Inc.Vor Bio to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:VORVor Biopharma Inc
03/02/202408:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
01/02/202411:36Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
01/02/202411:34Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
18/01/202408:01GlobeNewswire Inc.Vor Bio Doses First AML Patient with VCAR33 (ALLO) and Provides Corporate UpdateNASDAQ:VORVor Biopharma Inc
06/01/202409:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:VORVor Biopharma Inc
22/12/202308:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
02/12/202308:01GlobeNewswire Inc.Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)NASDAQ:VORVor Biopharma Inc
28/11/202300:00GlobeNewswire Inc.Vor Bio to Participate in the JMP Securities Hematology and Oncology SummitNASDAQ:VORVor Biopharma Inc
10/11/202308:01GlobeNewswire Inc.Vor Bio Presents Positive Data Update on Trem-cel at HSCT² ConferenceNASDAQ:VORVor Biopharma Inc
09/11/202308:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
09/11/202308:12Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:VORVor Biopharma Inc
08/11/202308:05GlobeNewswire Inc.Vor Bio Reports Third Quarter 2023 Financial Results and Provides Company UpdateNASDAQ:VORVor Biopharma Inc
08/11/202308:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:VORVor Biopharma Inc
 Showing the most relevant articles for your search:NASDAQ:VOR

Your Recent History

NYSE
NKE
Nike
ASX
XJO
S&P ASX 200
ASX
SUN
Suncorp
FTSE
UKX
FTSE 100
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
ASX
AMP
AMP
PM
XAUUSD
Gold vs US Dollar
COIN
ETHUSD
Ethereum
NYSE
JPM
JP Morgan Chase
ASX
ORG
Origin Energy
ASX
BHP
BHP
ASX
QBE
QBE Insurance
NASDAQ
MSFT
Microsoft
NYSE
DIS
Walt Disney
ASX
WES
Wesfarmers
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved